A pharmacist in the dentist's chair: could a new team approach tame stubborn mouth conditions?

NCT ID NCT07721090

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether adding a clinical pharmacist to dental care can improve how oral mucosal disorders — such as oral lichen planus, recurrent canker sores, burning mouth syndrome, oral thrush, and herpes infections — are managed. Dentists in some clinics will get pharmacist support to review prescriptions, counsel patients, and monitor for side effects. The study will compare prescribing quality, medication adherence, and symptom control between clinics using this model and those providing usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a pharmacist-led prescribing optimization and patient counselling program
What this could lead to
If effective, this model could become a standard way to improve medication safety and symptom control for common oral conditions in dental clinics.
What could go wrong
This is a relatively small, early-stage implementation trial. The benefit may depend on clinic resources and may not generalize to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNING MOUTH SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.